Profil
Maurus de la Rosa is Senior Vice President-Research at Abivax SA since 2026.
Formerly, Dr. de la Rosa was Vice President-Research at Sangamo Therapeutics,.
Inc. Education includes an undergraduate degree from Universität zu Köln and a doctorate from Humboldt-Universität zu Berlin.
Postes actifs de Maurus de la Rosa
| Sociétés | Poste | Début |
|---|---|---|
| ABIVAX | Directeur Technique/Scientifique/R&D | 19/03/2026 |
Anciens postes connus de Maurus de la Rosa
| Sociétés | Poste | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Maurus de la Rosa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
















